Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system and has been associated with several cognitive functions that are known to change with age. In rodents and humans age-related glutamate changes have been found in several brain areas. In this cross-sectional study the presence and extent of age-associated glutamate changes in the medial frontal cortex of healthy young adults were measured. Proton magnetic resonance spectroscopy ( 1 H-MRS) and brain imaging were performed at 7 T in a 2 Â 2 Â 2 cm 3 voxel in 33 participants between 18 and 31 years old. Glutamate concentrations and grey and white matter volume could be successfully determined at an ultra-high magnetic field strength. Glutamate concentrations were lower in older individuals (0.33 mM/year). This decline is in line with grey matter thinning in the medial frontal cortex, but could not be explained by cortical thinning alone. Therefore, the decrease in glutamate in young adulthood may be due to physiological changes rather than anatomical changes.
Introduction
Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system and principal neurotransmitter of cortical efferent systems (Fonnum, 1984) . Glutamate is involved in functions such as learning and memory (Cotman et al., 1988) , emotion and motivation (Cobo and Mora, 1991; Mora and Cobo, 1990 ) and motor behaviour (Schmidt et al., 1992) . The primary location of glutamate is in neurons and astrocytes. Only a small fraction of the total glutamate pool is present in the extracellular space. Glutamate is continuously released from cells and removed from the synaptic clefts and extracellular space. This removal is essential since exposure to high extracellular glutamate concentrations can have neurotoxic effects (Danbolt, 2001; Nedergaard et al., 2002) . This neurotoxicity has been implicated in neurodegenerative diseases like multiple sclerosis (Westall et al., 1980) , amyotrophic lateral sclerosis (Pioro et al., 1999 ), Alzheimer's dementia (Antuono et al., 2001 ), Parkinson's disease (Greenamyre, 1993) and schizophrenia (Olney and Farber, 1995) . Recently, meta-analysis showed a progressive decrease with age of glutamate concentrations in the frontal brain region in schizophrenia (Marsman et al., in press) , suggesting that too low levels of intra or extracellular glutamate may also be associated with neuropsychiatric diseases. Studying glutamate levels in normal maturation may contribute to elucidating the role of glutamate in cognitive decline in health and in neurological and neuropsychiatric disorders.
Studies in rodents as well as in humans have shown that age-related glutamate decreases occur in several brain areas, including motor areas, sensory areas and the hippocampus (Banay-Schwartz et al., 1989; Kaiser et al., 2005; Raininko and Mattsson, 2010) . Using these methods, in the rodent frontal cortex decreases in glutamate with age as well as neuronal loss have been found (Fornieles et al., 1986; Mufson and Stein, 1980; Segovia et al., 2001 ). Since glutamate is present in most cortical neurons, the observed decreases in glutamate may be associated with the agedependent neuronal pruning (Segovia et al., 2001) . In humans, the frontal cortex shows thinning with increasing age, which could be due to shrinkage of neurons as well as neuronal loss (Anderton, 2002; Brans et al., 2010) , and might possibly be correlated with decreases in glutamate concentrations. Structural brain changes in the frontal cortex in young adulthood (Hedman et al., 2012) suggest that there are physiological changes going on during young adulthood. However, at this point in time the physiology underlying these structural brain changes is not well understood.
In this study we measured glutamate concentrations in the medial frontal brain region of healthy, young adult subjects, using high-field magnetic resonance spectroscopy. Proton magnetic resonance spectroscopy ( 1 H-MRS) can be used to non-invasively measure metabolite concentrations in vivo. Until now, studies investigating glutamate during aging using 1 H-MRS were conducted at field strengths of 4 T or lower. Previous studies showed a decrease of glutamate with age in the mesial motor cortex between 26 and 54 years (Kaiser et al., 2005) and dorsolateral prefrontal cortex between 19 and 31 years ), a trend of an age-related glutamate decline in frontal white matter between 21 and 71 years (Chang et al., 2009) , and age-related increase of glutamate in the orbitofrontal cortex between 19 and 52 years (Grachev and Apkarian, 2000) . Since measurement of glutamate with 1 H-MRS is challenging at lower field strengths, due to its spectral overlap with glutamine, a magnetic field strength of 7 T was used in this study to accurately determine glutamate concentrations in the human brain. In addition, we measured N-acetyl aspartate (NAA), a marker of neuronal integrity, creatine, a marker of energy metabolism, and choline, a marker of membrane turnover (Maudsley et al., 2009) . Also, most of the previous studies compared a younger age group with an older age group, thereby not investigating the alterations occurring within each age group. We measured glutamate, NAA, creatine and choline, and the fractions of grey and white matter in the medial frontal cortex, which is an area that decreases in volume in young adulthood (Brans et al., 2010) , and has been reported to be decreased in schizophrenia (Hulshoff Pol et al., 2001) . With this study, we investigate the relation between glutamate levels in the frontal cortex and age within a group of young adults.
2. Method 2.1. Subjects 37 Healthy subjects (19 men and 18 women) participated in this study, after giving written informed consent as approved by the Medical Ethics Committee of the University Medical Center Utrecht, The Netherlands. Participants were between 18.3 and 31.5 years old (mean7SD=24.873.4 years). Participants had no major psychiatric or neurological history and no history of drug or alcohol abuse, as tested with the Mini International Neuropsychiatric Interview Plus (MINI-Plus) (Van Vliet et al., 2000) . Participants had no first-degree relatives with psychiatric or neurological disorders. Four volunteers were excluded from the study due to poor quality of MR spectra or the T 1 -weighted image. Hence, the results of this study are based on 33 subjects.
MRS acquisition
1 H-MRS experiments were performed on a 7 T whole body MR scanner (Philips, Cleveland, USA) with a birdcage transmit head coil (Nova Medical, Inc., Burlington, MA, USA) in combination with a 16-channel receive coil (Nova Medical, Inc., Burlington, MA, USA). First, a T 1 -weighted MP-RAGE sequence (450 slices, slice thickness =0.8 mm, TR =7 ms, TE=3 ms, flip angle=81, FOV=250 Â 200 Â 180 mm 3 , 312 Â 312 acquisition matrix, SENSE factor 2.7, scan duration=408 s) was obtained for anatomical reference and grey and white matter tissue classification.
After obtaining the anatomical image, MR spectra were acquired of the medial frontal brain region ( Figure 1 ). For this, a stimulated echo acquisition mode (STEAM) sequence (TR=2000 ms, TE=7 ms, TM= 11 ms, single voxel, voxel size =2 Â 2 Â 2 cm 3 , B 1 =20 mT) was used, placing the voxel of interest in the medial frontal cortex, in front of the genu of the corpus callosum. Water suppression was applied (SWAMP (De Graaf and Nicolay, 1998)) for obtaining the MR spectrum with glutamate, NAA, creatine and choline (acquisition time=260 s). An MR spectrum without water suppression was obtained for quantification (carrier frequency was set to the chemical shift of H 2 O, acquisition time=10 s). Second order B 0 shimming was based on the FASTERMAP algorithm (Gruetter, 1993; Gruetter and Boesch, 1992) . After selecting the volume of interest, local B 1 field was calibrated (Versluis et al., 2010) . Besides glutamate, we also quantified NAA, creatine and choline. ) was placed in the medial frontal cortex in front of the genu of the corpus callosum.
Spectral fitting and quantification
Spectral fitting was performed using the Accurate Quantitation of Short Echo time domain Signals (AQSES) algorithm, implemented in the Simulation Package based on In vitro Databases (SPID) (Poullet et al., 2007) .
Metabolite levels were estimated using the water signal as an internal reference. The concentration of each metabolite was calculated as follows: 
Statistical analysis
For regression analyses, the general linear model (GLM) was applied using the statistical environment R (R Development Core Team, 2006) , with metabolite concentration as the dependent variable and age, gender and grey matter fraction as independent variables. Grey matter fraction was calculated as follows:
where GMfraction is the proportion of grey matter to total brain tissue in the 1 H-MRS voxel, GM is the proportion of grey matter in the 1 H-MRS voxel, and WM is the proportion of white matter in the 1 H-MRS voxel.
Results
The glutamate resonance at 2.3 ppm was well resolved and could be obtained with a high signal to noise ratio and good spectral resolution as revealed by visual inspection of the spectrum (Figure 2 ). The glutamate concentration in the medial frontal cortex changed significantly with age (b=À0.33, t =À2.5, df =30, p =0.02; mean7SD=6.172.7) (Figure 3) . No significant effects of grey matter fraction (b=2.74, t=1.2, p=0.23) and gender (b=À0.42, t =0.5, p =0.65) were found.
NAA did not show any significant age-related changes (b=À0.1, t =1.3, p=0.22; mean7SD= 6.271.7) (Figure 4) . NAA did not have a significant association with the grey matter fraction in the voxel (b =2.14, t =1.4, p=0.16).
Creatine concentrations changed significantly with age (b=À0.22, t=À3.3, p=0.002; mean7SD=6.071.4) ( Figure 5 ). Creatine did not have significant associations with the grey matter fraction in the voxel (b=2.05, t=1.8, p=0.08) and gender (b=0.68, t=1.5, p=0.15).
Choline concentrations show an age-related decrease, however, this is not significant (b=À0.28, t =À1.9, p= 0.06; mean7SD=1.570.4) ( Figure 6 ). Choline did not have significant associations with the grey matter fraction in the voxel (b=0.44, t=2.4, p=0.86) and gender (b= 0.80, t =0.8, p =0.44).
Discussion
The main finding of this study is a decrease in glutamate concentration with age in a relatively small age range from 18 to 31 years in medial frontal cortex of the human brain. Concentrations of NAA, a marker of neuronal integrity, did not show any significant changes in this age range, which indicates that there are no alterations in brain tissue or Figure 2 A typical spectrum, as measured in this study using the stimulated echo acquisition mode (STEAM) at a magnetic field strength of 7 T in a 2 Â 2 Â 2 cm 3 voxel placed in the medial frontal cortex (Cr=creatine, PCr=phosphocreatine, Cho=choline, Gln=glutamine, Glu=glutamate, NAA=N-acetyl aspartate). neuronal function in this brain region in young adult individuals. This finding is further strengthened by the fact that grey matter volume did not reveal a significant influence on the age-related decline in glutamate in the medial frontal cortex.
In healthy aging, the 1 H-MRS profile of the human brain shows region-specific alterations, the largest alterations occurring in (pre)frontal brain regions and in particular in glutamate and GABA concentrations . Indeed, our findings corroborate that glutamate concentrations decrease with age in the human frontal cortex, already at a young adult age. In a meta-analysis of longitudinal MRIstudies of whole brain volume change in healthy individuals it was shown that there is a period of stable brain volume between 18 and 35 years of age (Hedman et al., 2012) , which supports the suggestion that the glutamate decline observed in this period has a physiological background and is not primarily a reflection of changes in brain volume. The alterations in glutamate concentration in the medial prefrontal cortex may precede changes in cortical volume or may reflect the consequence of cortical changes that occur during adolescence. During the transition from adolescence to adulthood synaptic density decreases and (mainly) glutamatergic synapses are eliminated, reflecting synaptic pruning (Bourgeois and Rakic, 1993; Craik and Bialystok, 2006; Sawa, 2009) . Interestingly, both glutamate levels (Bustillo et al., 2011; Cotman et al., 1988; Segovia et al., 2001 ) and efficiency of structural and functional brain networks (Gong et al., 2009; Lo et al., 2011; van den Heuvel et al., 2009; Wen et al., 2011) are associated with cognitive functioning. Thus, possibly the glutamate decline in young adulthood may reflect brain maturation.
The glutamate signal that is detected in the human brain by 1 H-MRS does not distinguish between glutamate used in metabolic pathways and glutamate used for neurotransmission. Since the majority of glutamate is present in the metabolic pool (Fonnum, 1993) , the decreases in glutamate are possibly due to changes in metabolic activity (Segovia et al., 2001; Zahr et al., 2008) . This may reflect a decreased neuronal integrity since glutamate is primarily located in neurons. However, we did not find any significant agerelated decline in the concentrations of NAA, which implies that it is unlikely that the decrease with age in glutamate concentration in the prefrontal cortex in these young adult humans represents changes in neuronal integrity. Indeed, it is more likely that the age-related decline in glutamate concentrations at this age point to changes in glutamatergic neurotransmission and neuronal metabolism. Changes in the regulation of glutaminase, the enzyme that converts glutamine into glutamate, are present in the aging brain Dawson, 1992, 1993) , which could lead to a reduction of the glutamine-glutamate cycle flux (Boumezbeur et al., 2009) . A decrease with age in the density of the NMDA-type of glutamate receptor has also been found (Petersen and Cotman, 1989) , possibly resulting in reduced uptake capacity (Segovia et al., 2001) . The age-related decline in glutamate could in turn result in reduced glutamate-receptor activation, in particular of the NMDA-type, which may lead to cognitive deficits (Krystal et al., 1994; Olney et al., 1999) . However, since there are no signs of cognitive alterations in young adulthood, and yet there are signs of synaptic pruning, the decrease in glutamate might alternatively suggest a higher efficiency of glutamate signalling in this period. The latter may possibly be a result of maturation of neural systems (Stoneham et al., 2010) . In fact, the agerelated decreases that were found for concentrations of creatine, a marker of energy metabolism, and choline, a marker of membrane turnover, support this notion.
The development of the glutamatergic neurotransmitter system during healthy maturation may also provide insight in pathologies underlying neurodegenerative diseases, like schizophrenia. Glutamate concentrations decrease progressively with age in patients with schizophrenia as compared with healthy individuals (Marsman et al., in press ). Since the results of this study show that glutamate concentrations in healthy individuals are declining with age as well, this implicates that glutamate levels in patients with schizophrenia decline at an even faster rate.
There are some points that have to be taken into consideration when interpreting its findings. The 1 H-MRS technique that was used in this study, STEAM, has the advantage of combining a short TE with a long TR, thereby reducing quantification errors due to T 1 and T 2 relaxations, which are possibly age-dependent (Kreis et al., 2005; Raininko and Mattsson, 2010) . However, STEAM suffers from signal to noise ratio (SNR) loss and only half of the available signal can be obtained, therefore, the application of newly developed 1 H-MRS sequences for 7 T might result in a better SNR and therefore more sensitive measures in the future (Boer et al., 2011) . Also, the use of water as an internal reference to calculate metabolite concentrations might induce quantification errors, since a possible decrease of water concentrations with age is not considered (Chang et al., 1996; Kaiser et al., 2005) . However, between 20 and 70 years of age, water concentrations in the medial frontal lobe do not show any significant changes (Brooks et al., 2001) . In this study, only a small age range was investigated. It would be interesting to examine glutamate levels at older ages as well, thus acquiring a complete profile of glutamate changes throughout adult life, which could help elucidate the physiology behind several neural processes that show age-related alterations.
In conclusion, this study shows a decline in glutamate concentrations in the medial frontal cortex in healthy young adulthood and no alterations in markers of neuronal integrity, suggesting there are physiological changes occurring in this age range.
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